Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Nov-24 6:04 PM View:  | Theravance Biopharma, Inc. (TBPH) | 20-Nov-24 | Payment of Exercise | 9,178 | $9.97 | $91,504.70 | (3%) 322.74K to 313.56K | 2% |
| 22-Aug-24 8:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 9,222 | $8.22 | $75,804.80 | (3%) 335.96K to 326.74K | (18%) |
| 12-Jul-24 6:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 10-Jul-24 | Market Sale (Planned) | 4,000 | $9.00 | $36,000.00 | (1%) 339.96K to 335.96K | (8%) |
| 22-May-24 6:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 9,268 | $9.10 | $84,338.80 | (3%) 349.23K to 339.96K | (7%) |
| 04-Apr-24 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 37,500 | -- | -- | 12% 311.73K to 349.23K | |
| 22-Feb-24 8:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 22-Feb-24 | Market Sale (Planned) | 1,254 | $8.71 | $10,922.30 | (< 1%) 312.99K to 311.73K | (12%) |
| 22-Feb-24 8:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 18,219 | $8.92 | $162,513.00 | (6%) 331.21K to 312.99K | (9%) |
| 22-Nov-23 6:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 21-Nov-23 | Market Sale (Planned) | 1,378 | $10.29 | $14,179.60 | (< 1%) 332.58K to 331.21K | 5% |
| 22-Nov-23 6:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 7,982 | $10.37 | $82,773.30 | (2%) 340.57K to 332.58K | 6% |
| 24-Aug-23 6:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 22-Aug-23 | Market Sale (Planned) | 1,807 | $9.47 | $17,112.30 | (< 1%) 342.37K to 340.57K | (3%) |
| 22-Aug-23 6:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-23 | Payment of Exercise | 10,460 | $9.70 | $101,462.00 | (3%) 352.83K to 342.37K | (< 1%) |
| 12-Jun-23 6:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Jun-23 | Private Sale (Planned) | 1,790 | $11.13 | $19,922.70 | (< 1%) 354.62K to 352.83K | |
| 23-May-23 7:40 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-23 | Payment of Exercise | 5,567 | $11.21 | $62,406.10 | (2%) 360.19K to 354.62K | |
| 13-Mar-23 5:57 PM View: | Theravance Biopharma, Inc. (TBPH) | 09-Mar-23 | Market Sale | 4,000 | $10.20 | $40,800.00 | (1%) 364.19K to 360.19K | 5% |
| 03-Mar-23 10:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Mar-23 | Grant | 75,000 | -- | -- | 26% 289.19K to 364.19K | |
| 22-Feb-23 7:18 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-23 | Payment of Exercise | 7,119 | $10.44 | $74,322.40 | (2%) 296.31K to 289.19K | 7% |
| 22-Nov-22 4:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-22 | Payment of Exercise | 23,268 | $10.85 | $252,458.00 | (7%) 319.58K to 296.31K | |
| 23-Aug-22 6:54 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Aug-22 | Payment of Exercise | 10,413 | $9.34 | $97,257.40 | (3%) 329.99K to 319.58K | (4%) |
| 24-May-22 7:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 23-May-22 | Market Sale (Planned) | 1,081 | $8.93 | $9,653.33 | (< 1%) 331.07K to 329.99K | (9%) |
| 24-May-22 7:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-22 | Payment of Exercise | 2,200 | $8.74 | $19,228.00 | (< 1%) 333.27K to 331.07K | (11%) |
| 02-Mar-22 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 28-Feb-22 | Market Sale (Planned) | 2,356 | $10.16 | $23,946.60 | (< 1%) 335.63K to 333.27K | 4% |
| 23-Feb-22 6:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-Feb-22 | Payment of Exercise | 11,824 | $9.61 | $113,629.00 | (3%) 347.45K to 335.63K | (1%) |
| 16-Dec-21 7:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Dec-21 | Grant | 27,500 | -- | -- | 9% 319.95K to 347.45K |